MetaCap

OmniAb (OABI) vs OneMedNet (ONMD)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.

Summary

OmniAb (OABI) has outperformed OneMedNet (ONMD) over the past year, gaining 166.3% versus a loss of 79.0%. Over five years, OABI leads with a -53.3% price change compared with -95.2% for ONMD. OmniAb is the larger company by market cap ($677.5 million vs $28.1 million), about 24.1 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

OABI+166.29%ONMD-79.04%
+201%+54%-92%
Oct 8, 20251 yearOct 8, 2026
OABI-53.17%ONMD-95.20%
+19%-42%-102%
Oct 4, 20215 yearsOct 5, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

OABI versus ONMD key metrics
MetricOABIONMD
Share price$4.66$4.82
Market cap$677.52M$28.08M
1-day change+2.19%-1.83%
YTD return+151.89%-56.18%
1-year return+166.29%-79.04%
5-year return-53.26%-95.21%
EPS (TTM)$-0.36$-1.60
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$5.43$42.20
52-week low$1.30$4.73
Distance from 52-week high-14.18%-88.58%
Analyst consensusstrong_buy—
Avg. price target upside+78.76%—
Average volume1.47M114.91K
Shares outstanding145.39M5.82M
Employees8922
SectorHealthcareHealthcare
IndustryBiotechnologyHealth Information Services

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • OmniAb is about 24.1 times larger than OneMedNet by market value ($677.52M vs $28.08M).
  • OABI has outperformed ONMD by 245.3 percentage points over the past year.

About OmniAb

OABI stock →

OmniAb, Inc., a biotechnology company, licenses discovery research technology to pharmaceutical and biotech companies, and academic institutions to enable the discovery of therapeutics in the United States, Europe, Japan, China, and Canada. The company's technology platform creates and screens diverse antibody repertoires to identify optimal antibodies and other target-binding proteins for partners' drug development efforts.

Healthcare · Biotechnology · 89 employees

About OneMedNet

ONMD stock →

OneMedNet Corporation, a healthcare software company, provides digital medical image management, exchange, and sharing solutions in the Americas, Europe, and the Middle East. It offers iRWD, which provides regulatory grade imaging and clinical data in the pharmaceutical, device manufacturing, contract research organizations, and artificial intelligence markets markets.

Healthcare · Health Information Services · 22 employees

OABI vs ONMD FAQ

Which is bigger, OmniAb or OneMedNet?

OmniAb (OABI) is larger, with a market capitalization of $677.52M compared with $28.08M for OneMedNet (ONMD).

Which stock has performed better over the past year, OABI or ONMD?

OABI returned +166.29% over the past 12 months, compared with -79.04% for ONMD (price return, excluding dividends). Past performance does not predict future results.

Are OmniAb and OneMedNet in the same industry?

Both are in the Healthcare sector, but in different industries: Biotechnology for OmniAb and Health Information Services for OneMedNet.

More comparisons